Hear Christopher McKim’s journey with moderate to severe plaque psoriasis and the latest clinical trial results from dermatologist, Dr. Christine Cornejo.

Join this discussion with moderator Archie Franklin as Christopher McKim, a BMS employee living with moderate to severe plaque psoriasis, and Dr. Christine Cornejo, Director and US Medical Engagement Lead for Dermatology and Rheumatology at BMS, offer a patient and physician’s perspective on treating plaque psoriasis from the inside. Listen as Chris presents his journey along with Dr. Cornejo addressing effectiveness and safety information with clinical trial results for a prescription oral treatment option.

The intent of this episode is to encourage those who have moderate to severe plaque psoriasis to work with their health care provider to find a treatment option that is right for them.

This episode is sponsored by Bristol Myers Squibb. For more information view Full Prescribing Information and Medication Guide .

·       (0:00)   Intro to Psoriasis Uncovered and guest welcome to Bristol Myers Squibb employee and patient Christopher McKim and Dr. Christine Cornejo, Director and US Medical Engagement Lead for Dermatology and Rheumatology at Bristol Myers Squibb.

·       (2:15)  Where the journey to finding the right treatment option for Chris and his moderate to severe plaque psoriasis began. 

·       (3:09)   The decision by Chris and his provider to try an oral systemic medication.

·       (3:28)  The effects and impact of an oral systemic treatment for Chris and his plaque psoriasis.

·       (4:09)   Dr. Cornejo addresses efficacy and clinical trials results.

·       (5:58)   Common side effects and safety concerns for the treatment Chris and his health care provider decided to try.  

·       (6:28)   Health considerations patients and providers should discuss prior to using a systemic treatment.   

·       (6:54)   What to do should side effects occur.

·       (7:10)   How Chris feels with clearer skin after making a change in treatment.

·       (8:14)   Indication and Important Safety Information.

Key Takeaways:

·       Moderate to severe plaque psoriasis is a systemic disease.   

·       If you’re ready to treat from the inside there is a treatment option that may help.  

·       Work with a health care provider to find the right treatment for moderate to severe plaque psoriasis.  

·       Be proactive by taking steps to learn about treatment options including effectiveness, side effects, safety concerns, and what should be discussed with a health care provider before beginning a new treatment for plaque psoriasis. 

Guest Bios:  

Christopher (Chris) McKim joined BMS in June of 2022. In his current role he is a Regional Marketer for the dermatology division, prior to that he provided support for 9 Therapeutic Area Specialists for the Pacific South District in the GI division.  Prior to joining BMS, Chris worked at Sanofi, J&J, Leo Pharma, and Sun Pharma in various field and home office roles.

Chris resides in beautiful San Diego with his family Susan (wife), Morgan 18, Maddy 16, Mason 14 and two Golden Retrievers and enjoys traveling, cooking and anything associated with the ocean (Deep Sea Fishing, S.C.U.B.A. diving, snorkeling, and boogie boarding).

Dr. Christine Cornejo joined Bristol Myers Squibb in 2024 as Director, Medical Engagement Lead for Dermatology and Rheumatology. Prior to joining BMS, she practiced dermatology at Brigham and Women’s Hospital and Dana-Farber Cancer Institute in Boston, MA, where she specialized in melanoma and high-risk skin cancer management and served as the Director of Confocal Microscopy. She also served as an Instructor at Harvard Medical School and led the Immunology and Infectious Diseases course for 1st year medical students.

Resources:

Current Oral Systemic Treatments

For additional questions about treatment options contact the NPF Patient Navigation Center